Frequently Asked Questions
The market is segmented based on Segmentation By Types (Chronic Kidney Disease Associated Pruritus, Chronic Liver Disease Associated Pruritus, Atopic Dermatitis Associated Pruritus, and Others), Drugs (Corticosteroids, Antihistamines, Counterirritants, and Others), Route of Administration (Injectable, Topical, Oral, and Others), End Users (Hospitals, Homecare, Specialty Clinics and Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retailers, and Others) – Industry Trends and Forecast to 2031
.
The Global Pruritus Drug Market size was valued at USD 7.61 USD Billion in 2023.
The Global Pruritus Drug Market is projected to grow at a CAGR of 5.1% during the forecast period of 2024 to 2031.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
